Free Trial
OTCMKTS:XYNO

Xynomic Pharmaceuticals (XYNO) Stock Price, News & Analysis

$2.22 0.00 (0.00%)
As of 06/23/2021

About Xynomic Pharmaceuticals Stock (OTCMKTS:XYNO)

Key Stats

Today's Range
$2.22
$2.22
50-Day Range
$2.22
$2.22
52-Week Range
$0.20
$3.84
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive XYNO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Xynomic Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

XYNO Stock News Headlines

Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.
Watson Pharmaceuticals
Elite Pharmaceuticals Inc.
See More Headlines

XYNO Stock Analysis - Frequently Asked Questions

Xynomic Pharmaceuticals' stock was trading at $2.22 at the start of the year. Since then, XYNO stock has increased by 0.0% and is now trading at $2.22.
View the best growth stocks for 2025 here
.

Shares of XYNO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
7/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
N/A
Current Symbol
OTCMKTS:XYNO
CIK
N/A
Fax
N/A
Employees
27
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (OTCMKTS:XYNO) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners